Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite
Status:
Withdrawn
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine wether the combination of Ramatroban/Montelukast is
as effective as Montelukast alone in patients with mild to moderate atopic asthma (GINA I and
II) sensitive to house dust mite. The test is performed by a specific inhalative provocation.